BR112019024040A2 - peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo - Google Patents

peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo Download PDF

Info

Publication number
BR112019024040A2
BR112019024040A2 BR112019024040-3A BR112019024040A BR112019024040A2 BR 112019024040 A2 BR112019024040 A2 BR 112019024040A2 BR 112019024040 A BR112019024040 A BR 112019024040A BR 112019024040 A2 BR112019024040 A2 BR 112019024040A2
Authority
BR
Brazil
Prior art keywords
gly
leu
ala
yde
gln
Prior art date
Application number
BR112019024040-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Taegon BAIK
Taek-Soo Kim
Dae-Seong Lim
Deuk-Young Goo
Original Assignee
Yuyu Pharma, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma, Inc. filed Critical Yuyu Pharma, Inc.
Publication of BR112019024040A2 publication Critical patent/BR112019024040A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112019024040-3A 2017-05-17 2018-05-17 peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo BR112019024040A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0061250 2017-05-17
KR20170061250 2017-05-17
PCT/KR2018/005673 WO2018225961A1 (ko) 2017-05-17 2018-05-17 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물

Publications (1)

Publication Number Publication Date
BR112019024040A2 true BR112019024040A2 (pt) 2020-09-24

Family

ID=64566301

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019024040-3A BR112019024040A2 (pt) 2017-05-17 2018-05-17 peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo

Country Status (13)

Country Link
US (1) US12037415B2 (cg-RX-API-DMAC7.html)
EP (1) EP3643723B1 (cg-RX-API-DMAC7.html)
JP (2) JP7680824B2 (cg-RX-API-DMAC7.html)
KR (2) KR102287226B1 (cg-RX-API-DMAC7.html)
CN (1) CN110945012A (cg-RX-API-DMAC7.html)
AU (1) AU2018281617B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019024040A2 (cg-RX-API-DMAC7.html)
CA (1) CA3063842A1 (cg-RX-API-DMAC7.html)
ES (1) ES2982308T3 (cg-RX-API-DMAC7.html)
MX (1) MX2019013799A (cg-RX-API-DMAC7.html)
RU (1) RU2766160C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201912110YA (cg-RX-API-DMAC7.html)
WO (1) WO2018225961A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12037415B2 (en) * 2017-05-17 2024-07-16 Yuyu Pharma, Inc. Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
BR112021023477A2 (pt) * 2019-05-21 2022-02-15 Eyebio Korea Novo composto peptídico, composição farmacêutica para prevenir ou tratar inflamação, composição de alimento para prevenir ou amenizar a inflamação e composição de cosmético tendo um efeito anti inflamatório
KR20210104460A (ko) * 2020-02-17 2021-08-25 주식회사 아이바이오코리아 고체상 합성법을 이용한 펩타이드의 제조 방법
WO2021191689A2 (en) * 2020-03-05 2021-09-30 Yuyu Pharma, Inc. Treatment of inflammatory diseases with peptides and pharmaceutical compositions
MX2024006997A (es) * 2021-12-13 2024-06-19 Eyebiokorea Inc Composicion para el tratamiento de la degeneracion macular que comprende un nuevo peptido.
KR102593936B1 (ko) * 2021-12-13 2023-10-27 주식회사 아이바이오코리아 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물
KR102587729B1 (ko) * 2023-02-27 2023-10-12 주식회사 아이바이오코리아 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
KR102673860B1 (ko) * 2023-08-10 2024-06-12 (주)케어젠 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤
UA113627C2 (xx) 2011-05-27 2017-02-27 Кристалічна форма циклоспорину a, фармацевтична композиція та спосіб лікування
WO2013079213A1 (en) 2011-11-30 2013-06-06 Xigen Inflammation Ltd. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
KR101438744B1 (ko) 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
KR101948156B1 (ko) 2013-12-10 2019-02-14 인제대학교 산학협력단 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물
KR101555296B1 (ko) 2013-12-10 2015-09-23 인제대학교 산학협력단 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물
KR101721059B1 (ko) 2014-12-26 2017-03-30 주식회사 아이바이오코리아 안구 표면 질환 예방 또는 치료용 약학조성물
KR101690539B1 (ko) 2015-07-30 2016-12-29 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
AU2016373364B2 (en) 2015-12-14 2019-07-11 Tsung-Chuan Ho Short synthetic peptide and uses thereof
KR101798183B1 (ko) * 2016-04-08 2017-11-15 주식회사 아이바이오코리아 건성안 예방 또는 치료용 약학조성물
ES2822289T3 (es) 2016-04-08 2021-04-30 Eyebio Korea Péptido a base de colágeno tipo II alfa-1 para su uso en el tratamiento de la degeneración macular
KR101795653B1 (ko) * 2016-05-19 2017-11-09 인제대학교 산학협력단 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물
KR20180074928A (ko) 2016-12-26 2018-07-04 주식회사 아이바이오코리아 건성안 예방 또는 치료용 동물 의약품 조성물
US12037415B2 (en) 2017-05-17 2024-07-16 Yuyu Pharma, Inc. Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient
TWI865470B (zh) * 2018-11-14 2024-12-11 南韓商柳柳製藥股份有限公司 治療眼睛疾病之肽及醫藥組合物
US11613558B2 (en) 2018-11-14 2023-03-28 Yuyu Pharma, Inc. Peptides and pharmaceutical compositions for treating eye diseases
WO2021191689A2 (en) * 2020-03-05 2021-09-30 Yuyu Pharma, Inc. Treatment of inflammatory diseases with peptides and pharmaceutical compositions

Also Published As

Publication number Publication date
JP7680824B2 (ja) 2025-05-21
JP2023098936A (ja) 2023-07-11
MX2019013799A (es) 2020-08-13
AU2018281617B2 (en) 2022-06-30
KR102498428B1 (ko) 2023-02-20
KR20210097670A (ko) 2021-08-09
EP3643723C0 (en) 2024-05-15
RU2019141646A (ru) 2021-06-17
JP7775250B2 (ja) 2025-11-25
EP3643723A1 (en) 2020-04-29
CN110945012A (zh) 2020-03-31
WO2018225961A1 (ko) 2018-12-13
US12037415B2 (en) 2024-07-16
EP3643723B1 (en) 2024-05-15
CA3063842A1 (en) 2019-12-09
AU2018281617A1 (en) 2019-12-05
KR102287226B1 (ko) 2021-08-11
EP3643723A4 (en) 2021-03-31
SG11201912110YA (en) 2020-01-30
US20210024577A1 (en) 2021-01-28
RU2766160C2 (ru) 2022-02-08
ES2982308T3 (es) 2024-10-15
RU2019141646A3 (cg-RX-API-DMAC7.html) 2021-07-28
KR20180126406A (ko) 2018-11-27
JP2020520372A (ja) 2020-07-09

Similar Documents

Publication Publication Date Title
JP7775250B2 (ja) 新規ペプチド及びその新規ペプチドを活性成分として含む眼疾患の治療のための医薬組成物
JP7522732B2 (ja) 眼疾患治療用のペプチド及び医薬組成物
JP6994454B2 (ja) ベンズアゾール化合物ならびに該化合物の作製方法および使用方法
WO2024088409A1 (zh) 一种含氮杂环化合物、其药学上可接受的盐及其制备方法与应用
TW200838536A (en) Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
WO2021191689A2 (en) Treatment of inflammatory diseases with peptides and pharmaceutical compositions
CN102665716B (zh) 用于治疗唐氏综合征的方法和药物组合物
WO2020143604A1 (zh) 一种二氢异喹啉类化合物
JP2022106788A (ja) 脂質化ペプチドの水溶性塩、その製造方法および用途
JP2006096712A (ja) Lpa受容体拮抗剤を含有する角膜知覚改善剤
CA3119921C (en) Peptides and pharmaceutical compositions for treating eye diseases
RU2819399C2 (ru) Пептиды и фармацевтические композиции для лечения глазных болезней
WO2022166923A1 (zh) 苯基二氢嘧啶类化合物及其应用
HK40017864A (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
HK40061089B (en) Peptides and pharmaceutical compositions for treating eye diseases
HK40061089A (en) Peptides and pharmaceutical compositions for treating eye diseases

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]